|
Dear all, It is a pleasure to have joined Episurf Medical as Head of Sales (Outside of U.S) in January and the first quarter has been a very busy period for us. Of course, the year started with Covid restrictions limiting in-person meetings but as they are now lifting, I am looking forward to connecting with many of our new and existing customers. There is no doubt that the Covid impact on health services across the world has been significant and, in most countries, elective surgeries continue to be in a state of recovery. It is encouraging to see many green shoots of recovery and a sure sign that we are returning to normality is the commencement of larger scale congress meetings – something our industry has missed dearly. We are excited to be participating in the ESSKA Congress in Paris, which takes place this week, April 27th - 29th. This is the first international meeting we will attend since the outbreak of the pandemic. If you are attending the ESSKA congress, please do take some time to attend our booth and meet the team. As part of the main agenda, we also are very pleased to be supported by Prof. Peter Verdonk and Prof. Niek van Dijk, who will share their experience as two of our most experienced Episealer® users.
These are exciting times for Episurf, as we hit important clinical milestones, have an expanding customer base and most importantly a continuous flow of positive patient testimonials.
Stephen Caswell
Head of Global Sales, OUS
| 
